Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left atrial appendage closure with the AnchorMan or Watchman devices: 12-month results of the SAFE-PROTECT randomised trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Comparative efficacy of oral and long-acting injectable paliperidone on social functioning in schizophrenia: A systematic review and meta-analysis.

Schizophrenia research·2026
Same author

Novel Transcatheter Edge-to-Edge Repair System for Degenerative Mitral Regurgitation: 1-Year Outcomes.

JACC. Asia·2026
Same author

WAT-to-BAT communication facilitates the sustained activation of BAT thermogenesis during cold exposure.

Cell discovery·2026
Same author

Transcriptional Heterogeneity of Cardiac Remodeling Between Type 1 and Type 2 Diabetes.

Biomedicines·2026
Same author

Multicenter Evaluation of an Edge-to-Edge Repair System in High-Risk Patients With Degenerative Mitral Regurgitation.

Structural heart : the journal of the Heart Team·2026

Related Experiment Video

Updated: Jun 20, 2025

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.5K

Endothelial dysfunction: molecular mechanisms and clinical implications.

Xia Wang1, Ben He1

  • 1Department of Cardiology Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China.

Medcomm
|July 23, 2024
PubMed
Summary
This summary is machine-generated.

Endothelial dysfunction is key to cardiovascular disease (CVD) and related conditions. This review details its mechanisms, impact, biomarkers, and treatments to reduce CVD risk.

Keywords:
cardiovascular diseaseendothelial dysfunctioninflammationnitric oxideoxidative stress

More Related Videos

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

27.3K
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

43.7K

Related Experiment Videos

Last Updated: Jun 20, 2025

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.5K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

27.3K
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

43.7K

Area of Science:

  • Cardiovascular Medicine
  • Pathophysiology
  • Molecular Biology

Background:

  • Cardiovascular disease (CVD) is a major global health concern.
  • Endothelial dysfunction is a critical factor in CVD development and progression.
  • Understanding the molecular mechanisms of endothelial dysfunction is incomplete.

Purpose of the Study:

  • To review recent findings on the pathophysiological mechanisms of endothelial dysfunction.
  • To discuss the impact of endothelial dysfunction on various diseases.
  • To summarize biomarkers and therapeutic strategies for endothelial protection and CVD treatment.

Main Methods:

  • Literature review of recent research findings.
  • Analysis of pathophysiological mechanisms including nitric oxide availability, oxidative stress, and inflammation.
  • Discussion of the role of endothelial dysfunction in atherosclerosis, heart failure, diabetes, hypertension, chronic kidney disease, and neurodegenerative diseases.

Main Results:

  • Endothelial dysfunction involves complex signaling pathways influenced by risk factors.
  • It impacts a wide range of pathological conditions.
  • Emerging biomarkers and therapeutic strategies offer potential for improved management.

Conclusions:

  • A comprehensive understanding of endothelial dysfunction mechanisms is crucial.
  • Novel biomarkers and therapeutic approaches are vital for reducing CVD risk.
  • Targeting endothelial dysfunction can mitigate CVD and associated complications.